Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04259840 · ClinicalTrials.gov registry record
Clinical Outcomes of Resective Surgical Treatment of Peri-Implantitis With or Without Implantoplasty
A clinical trial, sponsored by University of Michigan.
- Terminated
- Registry status
- 41
- Enrollment target
NCT04259840: Clinical Trial study, sponsored by University of Michigan.
NCT04259840 is a clinical trial that was terminated before completion, run by University of Michigan. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04259840 was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- 41 participants
- Enrollment target
Study Summary
The aims of the current study are 1) to assess the therapeutic resolution of the peri-implantitis after resective surgical treatment with or without implantoplasty procedure (no further radiographic bone loss, no erythema of the peri-implant mucosa, PD \<6mm), and 2) to evaluate the survival rate of the peri-implantitis treated dental implants.
Primary Outcome
The implant has no further radiographic bone loss when compared to previous radiographs.
Interventions
- OTHER Observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2019-12-05 |
| Est. Completion | 2020-07-01 |
Why NCT04259840 stopped before completion
NCT04259840 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Observation is the first listed.
NCT04259840 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04259840 about?
NCT04259840 is a clinical study titled "Clinical Outcomes of Resective Surgical Treatment of Peri-Implantitis With or Without Implantoplasty". The aims of the current study are 1) to assess the therapeutic resolution of the peri-implantitis after resective surgical treatment with or without implantoplasty procedure (no further radiographic bone loss, no erythema of the peri-implant mucosa, PD \<6mm), and 2) to evaluate the survival rate of...
What is the current status of trial NCT04259840?
This trial is currently terminated. The enrollment target is 41 participants. The study started on 2019-12-05. Estimated completion is 2020-07-01.
What interventions are being tested in trial NCT04259840?
The interventions under investigation include: Observation (OTHER).
Who is sponsoring clinical trial NCT04259840?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI